Arbor Research is proud to announce Dr. Ping Yu as Chief Growth Officer, where he will lead the Strategic Growth Team to expand Arbor Research's growth initiatives. Dr. Yu brings 40+ years of experience & expertise in contract research. Read more here: bit.ly/4b0RJEV

New paper with Karen Shen out today @HSR_HRET We find that the growth of Medicare Advantage has worsened nursing homes' finances. onlinelibrary.wiley.com/doi/10.1111/14…

Happy #WorldKidneyDay2024

The shift to Medicare Advantage is still the most under-recognized change taking place in health care

Just posted: Arnold Ventures has put together guidance for conducting power analyses of various causal research designs (RCTs and non-RCTs). Huge thanks to Stephen Billings, Jonah Gelbach, and Kevin Schnepel for their help with this. craftmediabucket.s3.amazonaws.com/uploads/EE_Pow…

The life size hashtag is impressive! Looking forward to a great day at CMS #QualCon24

If you think about Medicare policy, this article may be of interest It’s behind a paywall so feel free to reach out if you can’t access Hope to add a thread later nejm.org/doi/full/10.10…

Passed my defense, nearly PhDone!

Python for Econometrics slides: pyecon.org/down/pyecon.pdf

Dissertation revisions accepted! Just hours away from #PhDone

In case you missed it last week, we at Arbor Research are part of the big effort to modernize the organ transplantation system!

Computers are so annoying, complaining about caps lock AND not accepting my password!

It is nice to see #kidneywk still active on this site. I'll be following along from home this year. Keep us posted on the good stuff, Roberto Pecoits-Filho!

Our Health Services Organization & Policy Ph.D. program will host a virtual open house. Monday, Nov. 4th 6:00-7:00 PM ET Please register (email [email protected]) Overview of our curriculum, research initiatives, and the unique opportunities available within our community.

The Agency also finalized its proposal to pay for dental services for ESRD/dialysis patients, including dental or oral exams and treatment for infections in conjunction with Medicare-covered dialysis services for the treatment of end-stage renal disease.